Permanently DiscontinuedTier 3 — Critical

CEENU

BRISTOL-MYERS SQUIBB CANADA

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CEENU discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CEENU 40MG has been permanently discontinued (last updated February 11, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CEENU not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist

StatusPermanently Discontinued

Same-ingredient products on fileNone found

Affected strength40MG

Last updated2026-02-11

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00360422

Strength

40MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

LOMUSTINE

Tier

Tier 3 — Critical

Last Updated

2026-02-11

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from BRISTOL-MYERS SQUIBB CANADA

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ABRAXANE FOR INJECTABLE SUSPENSION

100MG · DIN 02281066

BARACLUDE

0.5MG · DIN 02282224

BREYANZI

120000000CELLS · DIN 02527138

CAMZYOS

15MG · DIN 02532573

CAMZYOS

5MG · DIN 02532557

CAMZYOS

2.5MG · DIN 02532549